cryptotanshinone has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, X; Han, J; Jia, D; Lv, T; Xu, X; Yao, H | 1 |
| Hiroshi, K; Jiang, T; Xu, JK; Yao, XS; Zheng, JJ | 1 |
2 other study(ies) available for cryptotanshinone and Liver Dysfunction
| Article | Year |
|---|---|
Cryptotanshinone ameliorates hemorrhagic shock-induced liver injury via activating the Nrf2 signaling pathway.
Topics: Animals; bcl-2-Associated X Protein; Cyclooxygenase 2; Cytochromes c; Liver Diseases; Male; NF-E2-Related Factor 2; Phenanthrenes; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Shock, Hemorrhagic; Signal Transduction | 2023 |
[Protective effect of tanshinones against liver injury in mice loaded with restraint stress].
Topics: Abietanes; Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Drugs, Chinese Herbal; Glutathione; Liver; Liver Diseases; Male; Malondialdehyde; Mice; Phenanthrenes; Plants, Medicinal; Protective Agents; Reactive Oxygen Species; Restraint, Physical; Salvia miltiorrhiza; Stress, Physiological | 2006 |